Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maf
|
ENSMUSG00000055435.6 | avian musculoaponeurotic fibrosarcoma oncogene homolog |
Nrl
|
ENSMUSG00000040632.9 | neural retina leucine zipper gene |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_115719204_115719355 | Maf | 11485 | 0.231179 | 0.59 | 1.7e-06 | Click! |
chr8_115825972_115826127 | Maf | 118255 | 0.059905 | 0.38 | 4.0e-03 | Click! |
chr8_115826662_115826813 | Maf | 118943 | 0.059373 | 0.34 | 1.1e-02 | Click! |
chr8_115826214_115826384 | Maf | 118505 | 0.059711 | 0.30 | 2.6e-02 | Click! |
chr8_115706865_115707065 | Maf | 131 | 0.961012 | -0.21 | 1.2e-01 | Click! |
chr14_55519015_55519218 | Nrl | 2151 | 0.120147 | -0.48 | 1.9e-04 | Click! |
chr14_55520440_55521261 | Nrl | 417 | 0.621267 | -0.29 | 3.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_147969452_147969633 | 12.27 |
Nppb |
natriuretic peptide type B |
16246 |
0.09 |
chr11_120382596_120382929 | 11.10 |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
741 |
0.43 |
chr14_14351950_14353283 | 9.28 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr2_155610966_155611319 | 8.04 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
70 |
0.93 |
chr8_12824634_12824821 | 7.36 |
Atp11a |
ATPase, class VI, type 11A |
2327 |
0.23 |
chr2_163353818_163354318 | 7.16 |
Tox2 |
TOX high mobility group box family member 2 |
33690 |
0.12 |
chr4_39398305_39398645 | 6.67 |
Gm17094 |
predicted gene 17094 |
51774 |
0.14 |
chr19_56378923_56379247 | 6.65 |
Nrap |
nebulin-related anchoring protein |
780 |
0.61 |
chr2_76807304_76807608 | 6.46 |
Ttn |
titin |
19086 |
0.23 |
chr8_125539375_125539842 | 6.33 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
30095 |
0.2 |
chr9_42461693_42462384 | 6.30 |
Tbcel |
tubulin folding cofactor E-like |
577 |
0.73 |
chr17_83916708_83917204 | 6.24 |
1810073O08Rik |
RIKEN cDNA 1810073O08 gene |
981 |
0.45 |
chr18_10784306_10784487 | 6.15 |
Mir1b |
microRNA 1b |
1050 |
0.24 |
chr7_130681888_130682051 | 6.08 |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
10587 |
0.18 |
chr18_35677563_35677741 | 6.07 |
Dnajc18 |
DnaJ heat shock protein family (Hsp40) member C18 |
9091 |
0.08 |
chr8_118588159_118588310 | 6.03 |
Gm45721 |
predicted gene 45721 |
22265 |
0.21 |
chr5_147589989_147590153 | 6.02 |
Flt1 |
FMS-like tyrosine kinase 1 |
25171 |
0.18 |
chr15_79690079_79691459 | 5.84 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr4_129256465_129256870 | 5.80 |
C77080 |
expressed sequence C77080 |
4737 |
0.13 |
chr5_133385739_133386398 | 5.80 |
Gm42625 |
predicted gene 42625 |
57274 |
0.15 |
chr1_85084738_85085997 | 5.78 |
Gm18342 |
predicted gene, 18342 |
5131 |
0.1 |
chr11_115899580_115900578 | 5.72 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr7_46116120_46116518 | 5.67 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
269 |
0.84 |
chr13_29627559_29627740 | 5.66 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
110195 |
0.07 |
chr2_163353659_163353810 | 5.61 |
Tox2 |
TOX high mobility group box family member 2 |
33356 |
0.12 |
chr12_104002871_104003031 | 5.60 |
Gm28577 |
predicted gene 28577 |
6372 |
0.11 |
chr2_166031086_166031786 | 5.49 |
Ncoa3 |
nuclear receptor coactivator 3 |
16482 |
0.15 |
chr1_135524592_135524802 | 5.46 |
Gm37333 |
predicted gene, 37333 |
641 |
0.67 |
chr3_52897740_52897907 | 5.46 |
Gm20750 |
predicted gene, 20750 |
29843 |
0.16 |
chr8_23142784_23143009 | 5.41 |
Mir3107 |
microRNA 3107 |
234 |
0.58 |
chr2_27209944_27210149 | 5.37 |
Sardh |
sarcosine dehydrogenase |
109 |
0.95 |
chr17_9407729_9407880 | 5.35 |
Gm17728 |
predicted gene, 17728 |
14256 |
0.19 |
chrX_6926420_6926600 | 5.25 |
Dgkk |
diacylglycerol kinase kappa |
53026 |
0.15 |
chr2_76982516_76982700 | 5.24 |
Ttn |
titin |
61 |
0.98 |
chr5_122137161_122137351 | 5.21 |
Ccdc63 |
coiled-coil domain containing 63 |
806 |
0.53 |
chr1_152738901_152739066 | 5.20 |
Gm7278 |
predicted gene 7278 |
8424 |
0.13 |
chr16_43701779_43702078 | 5.09 |
Gm49735 |
predicted gene, 49735 |
8904 |
0.16 |
chr4_14776259_14776453 | 5.08 |
Gm11838 |
predicted gene 11838 |
10021 |
0.2 |
chr11_117128065_117128508 | 5.08 |
Gm11745 |
predicted gene 11745 |
6312 |
0.13 |
chr16_94519149_94519474 | 5.04 |
Vps26c |
VPS26 endosomal protein sorting factor C |
7083 |
0.18 |
chr15_96802479_96802683 | 5.01 |
Gm8888 |
predicted gene 8888 |
35503 |
0.18 |
chr5_142540236_142540418 | 5.00 |
Radil |
Ras association and DIL domains |
4701 |
0.17 |
chr6_136898297_136898670 | 4.96 |
Mgp |
matrix Gla protein |
22660 |
0.09 |
chr18_55761914_55762508 | 4.96 |
Gm26959 |
predicted gene, 26959 |
15983 |
0.24 |
chr6_135364358_135364779 | 4.89 |
Emp1 |
epithelial membrane protein 1 |
1500 |
0.34 |
chr4_134293447_134293906 | 4.85 |
Pdik1l |
PDLIM1 interacting kinase 1 like |
5781 |
0.11 |
chr6_53605282_53605435 | 4.84 |
Creb5 |
cAMP responsive element binding protein 5 |
31982 |
0.2 |
chr16_16256778_16256952 | 4.82 |
Gm5481 |
predicted gene 5481 |
18738 |
0.15 |
chr8_85365030_85365187 | 4.76 |
Mylk3 |
myosin light chain kinase 3 |
216 |
0.91 |
chr4_86886652_86886836 | 4.76 |
Acer2 |
alkaline ceramidase 2 |
12330 |
0.21 |
chr13_32630202_32630413 | 4.72 |
AL645799.1 |
novel transcript |
16291 |
0.23 |
chr1_131431949_131432136 | 4.72 |
Gm29487 |
predicted gene 29487 |
15653 |
0.14 |
chr14_33244702_33244853 | 4.65 |
Arhgap22 |
Rho GTPase activating protein 22 |
5613 |
0.16 |
chr2_172430648_172430996 | 4.57 |
Rtf2 |
replication termination factor 2 |
9734 |
0.12 |
chr2_104467334_104467498 | 4.53 |
Hipk3 |
homeodomain interacting protein kinase 3 |
26274 |
0.13 |
chr13_44248521_44248688 | 4.52 |
Gm29676 |
predicted gene, 29676 |
4066 |
0.21 |
chr7_75404959_75405338 | 4.50 |
Gm44962 |
predicted gene 44962 |
15987 |
0.17 |
chr6_72671244_72671460 | 4.49 |
Tcf7l1 |
transcription factor 7 like 1 (T cell specific, HMG box) |
52 |
0.95 |
chr2_154206927_154207174 | 4.43 |
Bpifb1 |
BPI fold containing family B, member 1 |
6671 |
0.15 |
chr11_106677873_106678051 | 4.42 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
13385 |
0.16 |
chr4_117923568_117923746 | 4.42 |
Artn |
artemin |
5756 |
0.11 |
chr7_112310122_112310273 | 4.40 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
5832 |
0.31 |
chr8_116347015_116347319 | 4.40 |
1700018P08Rik |
RIKEN cDNA 1700018P08 gene |
9894 |
0.29 |
chr5_121809923_121810074 | 4.38 |
Atxn2 |
ataxin 2 |
666 |
0.56 |
chr6_33947005_33947225 | 4.37 |
Gm13853 |
predicted gene 13853 |
45296 |
0.16 |
chr2_76808433_76808586 | 4.35 |
Ttn |
titin |
18033 |
0.23 |
chr8_110711323_110711540 | 4.32 |
Mtss2 |
MTSS I-BAR domain containing 2 |
10045 |
0.16 |
chr15_77022950_77023101 | 4.31 |
Mb |
myoglobin |
238 |
0.87 |
chr10_42204903_42205075 | 4.30 |
Foxo3 |
forkhead box O3 |
53377 |
0.15 |
chr16_57563597_57563763 | 4.30 |
Filip1l |
filamin A interacting protein 1-like |
14438 |
0.23 |
chr9_102993048_102993199 | 4.29 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
4411 |
0.19 |
chr12_73764640_73764853 | 4.28 |
Gm8075 |
predicted gene 8075 |
28737 |
0.18 |
chr19_46459811_46459989 | 4.23 |
Sufu |
SUFU negative regulator of hedgehog signaling |
1994 |
0.27 |
chr15_83487585_83487761 | 4.23 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
23067 |
0.11 |
chr14_55004300_55004451 | 4.22 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
9749 |
0.07 |
chr5_24320568_24320732 | 4.20 |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
1604 |
0.25 |
chr1_120739638_120739818 | 4.19 |
Gm29346 |
predicted gene 29346 |
18715 |
0.2 |
chr2_32046160_32046311 | 4.19 |
Nup214 |
nucleoporin 214 |
3717 |
0.13 |
chr1_54684331_54684694 | 4.19 |
4930444A19Rik |
RIKEN cDNA 4930444A19 gene |
2783 |
0.25 |
chr9_67817979_67818144 | 4.17 |
C2cd4a |
C2 calcium-dependent domain containing 4A |
14269 |
0.16 |
chr1_51265118_51265462 | 4.15 |
Cavin2 |
caveolae associated 2 |
23836 |
0.18 |
chr1_179606204_179606380 | 4.15 |
Cnst |
consortin, connexin sorting protein |
12902 |
0.19 |
chr11_120386595_120387016 | 4.15 |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
3302 |
0.11 |
chr2_27181891_27182208 | 4.14 |
Dbh |
dopamine beta hydroxylase |
4956 |
0.13 |
chr7_109191268_109192295 | 4.12 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr4_31404863_31405047 | 4.09 |
Gm11922 |
predicted gene 11922 |
24483 |
0.28 |
chr6_115863592_115863787 | 4.09 |
Ift122 |
intraflagellar transport 122 |
10044 |
0.11 |
chr8_12259988_12260152 | 4.08 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
18749 |
0.17 |
chr8_126805357_126806196 | 4.07 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
33457 |
0.16 |
chr2_121551353_121551519 | 4.07 |
Frmd5 |
FERM domain containing 5 |
85 |
0.96 |
chr11_85799924_85800126 | 4.04 |
Bcas3 |
breast carcinoma amplified sequence 3 |
1796 |
0.24 |
chr15_36820211_36820408 | 4.04 |
Gm25303 |
predicted gene, 25303 |
21538 |
0.13 |
chr14_25711217_25711511 | 4.04 |
1700054O19Rik |
RIKEN cDNA 1700054O19 gene |
4091 |
0.16 |
chr15_102302559_102302908 | 4.03 |
Gm49480 |
predicted gene, 49480 |
6029 |
0.08 |
chr4_89469954_89470187 | 4.03 |
Gm12608 |
predicted gene 12608 |
25426 |
0.19 |
chr1_97761617_97761774 | 4.01 |
Ppip5k2 |
diphosphoinositol pentakisphosphate kinase 2 |
157 |
0.96 |
chr4_44029849_44030000 | 4.00 |
Clta |
clathrin, light polypeptide (Lca) |
17238 |
0.13 |
chr11_51647075_51647667 | 3.97 |
N4bp3 |
NEDD4 binding protein 3 |
3449 |
0.14 |
chr13_69563178_69563493 | 3.96 |
A530095I07Rik |
RIKEN cDNA A530095I07 gene |
19312 |
0.11 |
chr7_44378389_44378573 | 3.93 |
1700008O03Rik |
RIKEN cDNA 1700008O03 gene |
3451 |
0.09 |
chr1_78425763_78426361 | 3.90 |
Gm28995 |
predicted gene 28995 |
7290 |
0.18 |
chr17_49690948_49691127 | 3.89 |
Kif6 |
kinesin family member 6 |
23073 |
0.24 |
chr3_104599330_104600023 | 3.89 |
Gm26091 |
predicted gene, 26091 |
1563 |
0.27 |
chr17_71285963_71286291 | 3.88 |
Emilin2 |
elastin microfibril interfacer 2 |
11120 |
0.14 |
chr5_137786077_137787112 | 3.86 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr18_12490719_12490870 | 3.84 |
Gm29199 |
predicted gene 29199 |
8668 |
0.17 |
chr5_72472731_72472882 | 3.83 |
AU023070 |
expressed sequence AU023070 |
24298 |
0.12 |
chr13_37602443_37602615 | 3.82 |
Gm47753 |
predicted gene, 47753 |
20258 |
0.1 |
chr7_139310414_139310967 | 3.82 |
Gm32486 |
predicted gene, 32486 |
13825 |
0.18 |
chr13_57332049_57332200 | 3.80 |
Gm48176 |
predicted gene, 48176 |
55446 |
0.16 |
chr17_10473300_10473565 | 3.79 |
A230009B12Rik |
RIKEN cDNA A230009B12 gene |
8595 |
0.24 |
chr4_45469217_45469380 | 3.79 |
Shb |
src homology 2 domain-containing transforming protein B |
13504 |
0.16 |
chr16_15948306_15948472 | 3.79 |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
59973 |
0.1 |
chr4_134517051_134517242 | 3.78 |
Aunip |
aurora kinase A and ninein interacting protein |
6147 |
0.11 |
chr2_19553487_19554708 | 3.77 |
4921504E06Rik |
RIKEN cDNA 4921504E06 gene |
183 |
0.94 |
chr1_134910138_134910299 | 3.77 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
45633 |
0.11 |
chr1_135714923_135715239 | 3.77 |
Csrp1 |
cysteine and glycine-rich protein 1 |
4980 |
0.19 |
chr6_127274861_127275012 | 3.76 |
Gm7308 |
predicted pseudogene 7308 |
7573 |
0.13 |
chr19_36167625_36167790 | 3.75 |
Gm32081 |
predicted gene, 32081 |
14873 |
0.19 |
chr9_47376734_47376896 | 3.74 |
Gm31816 |
predicted gene, 31816 |
8166 |
0.27 |
chr10_3630824_3631112 | 3.73 |
Iyd |
iodotyrosine deiodinase |
90680 |
0.08 |
chr14_66308680_66308831 | 3.73 |
1700001G11Rik |
RIKEN cDNA 1700001G11 gene |
11626 |
0.15 |
chr17_5997809_5998028 | 3.72 |
Synj2 |
synaptojanin 2 |
1072 |
0.51 |
chr14_59230413_59230596 | 3.69 |
Rcbtb1 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 |
7916 |
0.18 |
chr5_32608110_32608261 | 3.69 |
Yes1 |
YES proto-oncogene 1, Src family tyrosine kinase |
2986 |
0.16 |
chr10_11171764_11171915 | 3.68 |
Shprh |
SNF2 histone linker PHD RING helicase |
5382 |
0.23 |
chr13_72023764_72023961 | 3.68 |
Irx1 |
Iroquois homeobox 1 |
60139 |
0.14 |
chr11_84028420_84028574 | 3.67 |
Synrg |
synergin, gamma |
1842 |
0.34 |
chr7_128549147_128549438 | 3.67 |
2610306O10Rik |
RIKEN cDNA 2610306O10 gene |
10360 |
0.12 |
chr18_21374872_21375224 | 3.67 |
Gm22886 |
predicted gene, 22886 |
5883 |
0.21 |
chr4_150089214_150089446 | 3.63 |
Gpr157 |
G protein-coupled receptor 157 |
1965 |
0.2 |
chr17_72275407_72275698 | 3.61 |
Gm19183 |
predicted gene, 19183 |
19294 |
0.28 |
chr1_193317140_193317601 | 3.56 |
Lamb3 |
laminin, beta 3 |
3325 |
0.16 |
chr6_83860131_83860286 | 3.55 |
Zfp638 |
zinc finger protein 638 |
6901 |
0.09 |
chr9_58817824_58817999 | 3.55 |
Hcn4 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 4 |
5501 |
0.26 |
chr8_33997799_33997965 | 3.54 |
Gm45817 |
predicted gene 45817 |
10682 |
0.15 |
chr9_44087883_44088081 | 3.53 |
Usp2 |
ubiquitin specific peptidase 2 |
792 |
0.35 |
chr10_94107198_94107406 | 3.53 |
Gm48372 |
predicted gene, 48372 |
1437 |
0.32 |
chr10_60078550_60079082 | 3.52 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
27403 |
0.16 |
chr18_40252766_40252921 | 3.50 |
Kctd16 |
potassium channel tetramerisation domain containing 16 |
4119 |
0.21 |
chr13_110929688_110929864 | 3.50 |
4930526H09Rik |
RIKEN cDNA 4930526H09 gene |
25930 |
0.16 |
chr5_107793329_107793480 | 3.49 |
Evi5 |
ecotropic viral integration site 5 |
6142 |
0.13 |
chr3_147287433_147287899 | 3.48 |
Gm6074 |
predicted gene 6074 |
94748 |
0.08 |
chr11_87005447_87005718 | 3.48 |
Gm22387 |
predicted gene, 22387 |
8319 |
0.15 |
chr1_76083417_76083591 | 3.48 |
Gm29068 |
predicted gene 29068 |
27076 |
0.23 |
chr7_80923282_80923433 | 3.47 |
Sec11a |
SEC11 homolog A, signal peptidase complex subunit |
201 |
0.89 |
chr16_26185747_26186199 | 3.47 |
P3h2 |
prolyl 3-hydroxylase 2 |
80189 |
0.11 |
chr12_70611969_70612120 | 3.47 |
Gm24474 |
predicted gene, 24474 |
38138 |
0.13 |
chr2_145017728_145017879 | 3.46 |
Gm11746 |
predicted gene 11746 |
86125 |
0.09 |
chr10_4079344_4079540 | 3.46 |
Gm25515 |
predicted gene, 25515 |
24871 |
0.17 |
chr19_3353424_3354027 | 3.45 |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
12098 |
0.13 |
chr6_97918028_97918368 | 3.45 |
Mitf |
melanogenesis associated transcription factor |
11601 |
0.24 |
chr3_58181856_58182023 | 3.45 |
4921539H07Rik |
RIKEN cDNA 4921539H07 gene |
18007 |
0.17 |
chr13_102593423_102593782 | 3.44 |
Gm29927 |
predicted gene, 29927 |
3317 |
0.28 |
chr3_51915985_51916486 | 3.44 |
Gm10728 |
predicted gene 10728 |
7419 |
0.13 |
chr2_12033740_12033927 | 3.43 |
Gm13310 |
predicted gene 13310 |
50159 |
0.14 |
chr8_13254012_13254383 | 3.43 |
Adprhl1 |
ADP-ribosylhydrolase like 1 |
35 |
0.95 |
chr2_114130778_114130930 | 3.42 |
Aqr |
aquarius |
10289 |
0.18 |
chr2_27206188_27206812 | 3.41 |
Sardh |
sarcosine dehydrogenase |
3437 |
0.17 |
chr15_97590838_97591009 | 3.41 |
Gm49506 |
predicted gene, 49506 |
32633 |
0.19 |
chr4_144905112_144905292 | 3.41 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
11983 |
0.2 |
chr19_5827433_5827790 | 3.40 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
401 |
0.66 |
chr1_51514407_51514599 | 3.38 |
Gm17767 |
predicted gene, 17767 |
2174 |
0.3 |
chr17_49738324_49738518 | 3.38 |
Kif6 |
kinesin family member 6 |
332 |
0.93 |
chr1_43196676_43196986 | 3.38 |
Fhl2 |
four and a half LIM domains 2 |
70 |
0.97 |
chrX_99531304_99531461 | 3.37 |
Pja1 |
praja ring finger ubiquitin ligase 1 |
60109 |
0.12 |
chr3_85880763_85880991 | 3.37 |
Gm37240 |
predicted gene, 37240 |
6491 |
0.11 |
chr19_56390005_56390331 | 3.36 |
Nrap |
nebulin-related anchoring protein |
131 |
0.96 |
chr10_60445293_60445528 | 3.36 |
Cdh23 |
cadherin 23 (otocadherin) |
38957 |
0.16 |
chr5_140217185_140217336 | 3.36 |
Gm16120 |
predicted gene 16120 |
7718 |
0.19 |
chr3_86017588_86017771 | 3.35 |
Prss48 |
protease, serine 48 |
15188 |
0.13 |
chr3_152143047_152143198 | 3.35 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
3666 |
0.16 |
chr8_106527314_106527465 | 3.35 |
Cdh3 |
cadherin 3 |
16498 |
0.16 |
chr3_101596309_101596515 | 3.34 |
Gm42941 |
predicted gene 42941 |
718 |
0.65 |
chr7_80445219_80445911 | 3.33 |
Blm |
Bloom syndrome, RecQ like helicase |
11807 |
0.12 |
chr4_100297822_100297973 | 3.33 |
Gm12706 |
predicted gene 12706 |
64162 |
0.13 |
chr2_77043015_77043177 | 3.32 |
Ccdc141 |
coiled-coil domain containing 141 |
984 |
0.61 |
chr15_36855074_36855317 | 3.32 |
Gm49282 |
predicted gene, 49282 |
12379 |
0.16 |
chr3_65658208_65659857 | 3.30 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr3_56471217_56471781 | 3.30 |
Gm25727 |
predicted gene, 25727 |
26087 |
0.26 |
chr18_11349188_11349349 | 3.29 |
Gm50067 |
predicted gene, 50067 |
275647 |
0.01 |
chr5_67695436_67695587 | 3.29 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
35477 |
0.12 |
chr11_116868252_116868403 | 3.29 |
Mfsd11 |
major facilitator superfamily domain containing 11 |
41 |
0.96 |
chr4_48403164_48403362 | 3.28 |
Invs |
inversin |
21075 |
0.2 |
chr9_32949151_32949302 | 3.27 |
Gm27162 |
predicted gene 27162 |
20260 |
0.18 |
chr6_145457135_145457443 | 3.27 |
Lmntd1 |
lamin tail domain containing 1 |
6522 |
0.16 |
chr1_187911245_187911422 | 3.26 |
Esrrg |
estrogen-related receptor gamma |
86494 |
0.09 |
chr1_12345554_12345745 | 3.26 |
Gm22633 |
predicted gene, 22633 |
29287 |
0.23 |
chr6_145760748_145760899 | 3.25 |
Rassf8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
10252 |
0.2 |
chr4_149277543_149277907 | 3.24 |
Kif1b |
kinesin family member 1B |
29746 |
0.12 |
chr4_129572356_129572507 | 3.24 |
Lck |
lymphocyte protein tyrosine kinase |
1210 |
0.25 |
chr3_149354109_149354276 | 3.23 |
Gm26468 |
predicted gene, 26468 |
13184 |
0.19 |
chr10_57115090_57115241 | 3.23 |
Gm40652 |
predicted gene, 40652 |
2057 |
0.41 |
chr4_49073007_49073160 | 3.23 |
Plppr1 |
phospholipid phosphatase related 1 |
13627 |
0.26 |
chr1_90980640_90980802 | 3.23 |
Gm28199 |
predicted gene 28199 |
5461 |
0.15 |
chr17_73014151_73014450 | 3.23 |
Gm30420 |
predicted gene, 30420 |
14778 |
0.2 |
chr3_21407206_21407362 | 3.22 |
Gm29137 |
predicted gene 29137 |
138194 |
0.05 |
chr12_117744604_117744880 | 3.22 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
4147 |
0.25 |
chr1_184064343_184064509 | 3.22 |
Dusp10 |
dual specificity phosphatase 10 |
30045 |
0.19 |
chr7_122821317_122821516 | 3.21 |
Gm29759 |
predicted gene, 29759 |
16547 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.5 | 9.2 | GO:0015671 | oxygen transport(GO:0015671) |
1.4 | 4.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.4 | 5.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 3.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.2 | 3.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.1 | 4.5 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
1.1 | 3.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 10.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.0 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.0 | 3.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.0 | 2.9 | GO:0040031 | snRNA modification(GO:0040031) |
0.9 | 6.6 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.9 | 2.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.9 | 1.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.9 | 0.9 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.8 | 4.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 2.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.8 | 4.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 2.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.8 | 6.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.8 | 7.7 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.7 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 2.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 2.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.7 | 2.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.7 | 2.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.7 | 1.4 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.7 | 2.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 1.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.7 | 2.7 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.7 | 2.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.7 | 2.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 4.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.7 | 2.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.6 | 1.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 1.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 2.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.6 | 0.6 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 1.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 1.9 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.6 | 2.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.6 | 1.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 2.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 1.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.6 | 2.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.6 | 1.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 4.7 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.6 | 1.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 0.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 1.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.6 | 1.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 2.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 1.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.5 | 1.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 2.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 1.6 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.5 | 2.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.5 | 4.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 1.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.5 | 2.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.5 | 2.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 1.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 2.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 1.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 1.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 1.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.5 | 1.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 1.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.5 | 3.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 2.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 1.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.5 | 2.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.5 | 0.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 3.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 5.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 1.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 1.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 1.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 0.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 1.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 3.0 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.4 | 1.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.4 | 8.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.4 | 1.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 0.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.4 | 1.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.4 | 0.4 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 2.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 0.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 1.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 1.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 4.6 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.4 | 0.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 3.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.8 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 0.8 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.4 | 1.5 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.4 | 8.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.4 | 0.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 8.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 1.8 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.4 | 1.8 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 1.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.3 | 0.3 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.3 | 1.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 4.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 0.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.3 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 0.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 1.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 1.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 3.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 1.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 1.3 | GO:0016202 | regulation of striated muscle tissue development(GO:0016202) |
0.3 | 1.0 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.3 | 0.9 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 1.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.3 | 3.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.3 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 1.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 2.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 8.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 5.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 1.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 1.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.9 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 2.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 1.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 2.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.6 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.3 | 0.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.3 | 0.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.9 | GO:0048382 | mesendoderm development(GO:0048382) |
0.3 | 1.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 2.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 0.8 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 3.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 0.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 0.3 | GO:0035789 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 2.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 2.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.7 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 1.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 0.6 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.3 | 1.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 1.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.3 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 2.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 5.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 1.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 0.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.6 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 2.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 0.8 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.3 | 0.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 0.5 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 0.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 2.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 0.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 2.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.3 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.3 | 0.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 0.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.3 | 0.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 1.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 3.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 3.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 1.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 2.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 2.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.7 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.5 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 1.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 2.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 0.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.7 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 4.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 4.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 2.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.2 | 2.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 1.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 4.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.4 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.6 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 2.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 4.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.2 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 2.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.2 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 1.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.2 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 0.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 1.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.6 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 2.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 1.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 7.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.2 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.8 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 1.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.4 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.2 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 1.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.2 | 0.4 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 1.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.8 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.1 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 3.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 1.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 1.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.9 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.2 | 1.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.6 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 0.5 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 1.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 1.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 2.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 1.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 1.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.5 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 1.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 1.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.2 | 0.2 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 1.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.2 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 1.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.2 | 2.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.7 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.2 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.3 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.2 | 0.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.6 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.2 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 1.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 1.4 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 1.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 1.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.8 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.2 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 0.5 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.2 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.2 | 0.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.8 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 2.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 0.5 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 2.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.2 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.2 | 0.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.9 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 1.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.1 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 1.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.8 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 2.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.7 | GO:0070254 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.1 | 0.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0006203 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.1 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.1 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 1.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.4 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 2.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 1.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 2.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 1.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.4 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 1.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.4 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 1.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 2.9 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.6 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 1.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 1.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.1 | 1.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.8 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.7 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.5 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 2.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 3.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 1.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.7 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 1.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.4 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 1.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.5 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.1 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.2 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 1.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 1.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 1.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.8 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.1 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 4.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.9 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) negative regulation of plasminogen activation(GO:0010757) |
0.1 | 1.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 2.7 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 1.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.6 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 2.5 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 1.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 1.8 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0016246 | RNA interference(GO:0016246) production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 1.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.7 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 0.2 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.1 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 2.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.1 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 1.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.6 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.2 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.5 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.1 | 0.1 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 1.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.9 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.2 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.1 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.5 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.2 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.1 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.1 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.2 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.6 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.9 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.4 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 1.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.2 | GO:1900042 | regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.1 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.1 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.1 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.1 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:0051029 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.1 | 0.1 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.8 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.3 | GO:0002534 | cytokine production involved in inflammatory response(GO:0002534) |
0.1 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.1 | 0.8 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 1.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.9 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.3 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.6 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 1.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 1.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.4 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.1 | 0.4 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.1 | 0.2 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.2 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.8 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.1 | 0.3 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.2 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 1.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 2.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 1.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.2 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) |
0.1 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.5 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 1.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.2 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 1.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.2 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
0.0 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 1.4 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.2 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.0 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.0 | GO:0070989 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.3 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.5 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 3.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.0 | 0.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 1.4 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.3 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 0.0 | GO:0002718 | regulation of cytokine production involved in immune response(GO:0002718) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.5 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:0034103 | regulation of tissue remodeling(GO:0034103) |
0.0 | 0.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.1 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide metabolic process(GO:0070813) hydrogen sulfide biosynthetic process(GO:0070814) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.0 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.2 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 2.0 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.9 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.4 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.0 | GO:0034381 | plasma lipoprotein particle clearance(GO:0034381) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 2.3 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.2 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.2 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0046208 | polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.3 | GO:0046031 | ADP metabolic process(GO:0046031) |
0.0 | 0.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.1 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0099587 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.2 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0055002 | striated muscle cell development(GO:0055002) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.0 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.0 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.0 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.0 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.0 | 0.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0003230 | cardiac atrium morphogenesis(GO:0003209) cardiac atrium development(GO:0003230) |
0.0 | 0.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.7 | 8.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.4 | 12.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 2.9 | GO:0005914 | spot adherens junction(GO:0005914) |
0.9 | 1.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.9 | 7.0 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 6.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.7 | 5.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 3.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 1.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 2.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 6.9 | GO:0031430 | M band(GO:0031430) |
0.6 | 1.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.6 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 7.2 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.5 | 3.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 1.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 4.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 8.8 | GO:0031672 | A band(GO:0031672) |
0.5 | 1.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 8.0 | GO:0043034 | costamere(GO:0043034) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 1.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 0.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 4.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.4 | 2.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 1.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 3.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 2.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 2.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 2.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 3.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 5.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 17.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 2.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 2.0 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 3.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 2.2 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 2.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 1.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 0.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 0.8 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 1.9 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 0.5 | GO:0043256 | laminin complex(GO:0043256) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 2.3 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 4.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 1.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 8.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.9 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 2.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 16.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 3.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 4.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 1.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 3.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 2.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 3.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 15.9 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.2 | 7.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.8 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 9.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 8.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 0.9 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 4.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 1.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 2.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 3.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 1.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 5.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 3.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 29.1 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 2.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 5.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 4.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 5.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 1.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 3.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 2.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 9.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 2.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 15.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 3.6 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 1.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 12.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 6.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 3.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 1.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 2.2 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.1 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.5 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 1.8 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 1.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 1.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 2.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 1.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.0 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 2.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 1.4 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.8 | 5.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.7 | 11.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.5 | 9.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.3 | 3.9 | GO:0050692 | DBD domain binding(GO:0050692) |
1.3 | 5.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.2 | 6.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 2.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 3.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 4.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.8 | 0.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.8 | 3.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 4.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.8 | 5.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 6.8 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 2.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.7 | 7.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 2.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 9.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 3.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.6 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 1.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 4.3 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 1.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.6 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 1.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 2.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 2.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 2.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 3.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 3.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 2.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 2.2 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 3.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 1.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 1.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 2.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.5 | 1.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.5 | 5.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 4.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 1.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 3.1 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 1.6 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 3.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 3.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 1.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 0.7 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.4 | 1.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 1.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 1.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 1.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 0.7 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.3 | 2.9 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 1.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 2.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 5.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 1.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.3 | 1.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.8 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 3.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 4.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.9 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.8 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 5.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 2.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 5.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 4.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 2.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 2.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 2.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 2.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 6.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 3.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.9 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 0.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 2.2 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 2.4 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 3.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 1.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.8 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.2 | 3.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 3.7 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 3.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.6 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 10.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 4.8 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 1.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 1.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 2.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 2.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 1.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 3.2 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 15.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.2 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.2 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 1.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 3.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.6 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 13.7 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 5.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.7 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 2.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 3.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 10.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 7.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.2 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.9 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 1.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.9 | GO:0034865 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 3.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0034806 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.7 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 1.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 2.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 3.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 3.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 1.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.5 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 4.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 1.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 11.2 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.8 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 2.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 8.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 6.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 3.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.2 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.8 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 4.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.2 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 2.8 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 1.3 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 1.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.6 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.0 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 2.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 2.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 1.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 2.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 3.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 1.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 2.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 1.3 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.9 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 3.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 4.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 2.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.5 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 2.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 8.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 3.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 14.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 6.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 7.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 8.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 13.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 5.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 7.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 5.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 1.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 7.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 8.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 10.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 5.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 3.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 8.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 3.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 5.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 10.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 3.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 5.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 6.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 5.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 4.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 6.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 5.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 13.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 7.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 3.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.7 | 7.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 19.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 5.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 8.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 5.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 3.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 6.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 3.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 2.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 3.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 9.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 6.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 3.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 1.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 3.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 0.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 2.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 4.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 7.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 1.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 5.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 4.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 0.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 1.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 5.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.4 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 1.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 1.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 11.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.5 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 4.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 3.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 2.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 2.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 6.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 6.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 2.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 3.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 3.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 2.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 8.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 2.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 7.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.1 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 3.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 1.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 4.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |